CDKN2C and lymphoma: p18−/−;Gata3+/− spleens and lymph nodes with lymphomas exhibited aberrant B220+IgM− or B220+IgM+ cell populations relative to age-matched tumor-free counterparts of the same genotype (Figure 5A).